Department of Pediatrics, Division of Infectious Diseases, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Division of Pediatric Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California, USA.
J Pediatric Infect Dis Soc. 2022 Dec 7;11(Supplement_4):S132-S140. doi: 10.1093/jpids/piac099.
Coronavirus disease 2019 (COVID-19) is an important cause of morbidity in children in the United States (U.S.). Moreover, the U.S. has witnessed significant disparities affecting American Indian/Alaska Native, Black, and Hispanic/Latino children, stemming from systemic racism and social-structural inequalities and not differences in innate biological susceptibility. We review what is known on COVID-19 and health disparities in disease burden, access to care, pharmaceutical interventions, and clinical research in children, with a focus on the U.S. context. In addition, we propose strategies to communicate scientific data in ways that do not promote racism and biological susceptibility themes, and to address pediatric disparities in clinical infectious diseases research.
新型冠状病毒病 2019（COVID-19）是美国儿童发病率的重要原因。此外，美国存在影响美国印第安人/阿拉斯加原住民、黑人和西班牙裔/拉丁裔儿童的重大差异，这些差异源于系统性种族主义和社会结构不平等，而不是内在生物学易感性的差异。我们回顾了 COVID-19 以及疾病负担、获得医疗保健、药物干预和儿童临床研究方面的健康差异方面的已知情况，重点是美国的情况。此外，我们提出了一些策略，以不促进种族主义和生物学易感性主题的方式来传达科学数据，并解决临床传染病研究中的儿科差异问题。
